Neostigmine methylsulfate

甲硫酸新斯的明

Report date: 2023/02/20 18:07:36
NME

Base Information

Drug NameNeostigmine methylsulfate
Drug Alias Name甲基硫酸新斯的明StiglynMetastigminJuvastigminBloxiverz +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsMuscle relaxation antagonists
TargetsAcetylcholinesterase
Therapy Area/IndicationsNeuromuscular BlockadeFlatulenceUrinary Retention +[5] 
Global Approved IndicationsNeuromuscular BlockadeFlatulenceUrinary Retention +[5] 
Approved Indications in ChinaFlatulenceUrinary RetentionMuscle Hypotonia +[4] 
Original Approved Country/TerritoryJapan
Original Approved Date1936/10/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active Companieskyowayakuhin CoExela Pharma Sciences LlcShanghai Sine Jinzhu Pharmacy Co Ltd
Inactive CompaniesN/A
Active IndicationsNeuromuscular BlockadeFlatulenceUrinary Retention +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN07AA01S01EB06
Related LinksWikipediaDrugBankKEGG